Semler Scientific (SMLR) has disclosed a new risk, in the Litigation & Legal Liabilities category.
Semler Scientific’s “Use of Proceeds” section has been marked as “Not Applicable,” indicating a potential lack of transparency or a stage in operations where the allocation of capital isn’t defined. This ambiguity presents a business risk, as investors and analysts may question the company’s financial strategies and future plans. Without clear insight into how funds are being utilized, it’s challenging to assess the efficacy of Semler Scientific’s financial management, possibly affecting investor confidence and market perception. This could ultimately impact the company’s ability to raise additional capital or manage cash flows effectively.
The average SMLR stock price target is $65.00, implying 183.10% upside potential.
To learn more about Semler Scientific’s risk factors, click here.
